FundedIQ
Biotechnology

Vial: Funding, Investors & Team (Oct 2026)

Vial is a biotechnology company that offers innovative programs for clinics to carry out more affordable trials. Their focus is on computationally designed treatments and utilizing technology to streamline clinical trial processes.

vial.com LinkedIn San Francisco, United States 101-250 employees
Biotechnology Health Care Medical Pharmaceutical
Total raised
$10.0M
Rounds
1
Latest
Undisclosed round
Jun 2025

Vial has raised $10.0M across 1 funding round on record, the most recent an undisclosed round of $10.0M announced in Jun 2025.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Vial Company Profile and Key Stats

Total funding raised
$10.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$10.0M in Jun 2025
Employees
101-250
reported band
Headquarters
San Francisco, United States

Latest funding round on record: Jun 2025.

Vial Funding Rounds

Date
Round
Amount
Undisclosed round
$10.0M

Vial Founders and Leadership Team

Name
Role
Contact
Simon Burns
Founder
—

No contact details are on record for this team yet.

Vial Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M

Vial's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Vial in Biotechnology and San Francisco

Companies Similar to Vial

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Vial Funding FAQs

What does Vial do?

Vial is a biotechnology company that offers innovative programs for clinics to carry out more affordable trials. Their focus is on computationally designed treatments and utilizing technology to streamline clinical trial processes.

How much funding has Vial raised?

Vial has raised $10.0M across 1 round on record. The most recent is an undisclosed round of $10.0M announced in Jun 2025.

When did Vial last raise funding?

Vial's most recent funding round on record is an undisclosed round of $10.0M, announced in Jun 2025.

Who founded Vial?

FundedIQ lists Simon Burns (Founder) at Vial.

Where is Vial headquartered?

Vial is based in San Francisco, California, United States.

How many employees does Vial have?

Vial is in the 101-250 employee band.

How does Vial's funding compare to other Biotechnology startups?

Vial's latest round of $10.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Vial Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vial is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.